Jonathan Schwartz

Jonathan Schwartz

Company: Rocket Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Optimizing Muscle Targeting 2:00 pm

Evaluating the vectors and promoters currently used for muscular disorders Discussing the challenges and opportunities of current vector discovery approaches Which vectors are showing preclinical promise for the muscle? Is non-viral a viable option?Read more

day: Post-Conference Day

Targeting Cardiac Muscle with AAV: Past, Present & Future 1:30 pm

AAV9 cardiotropism: pre-clinical and clinical evidence AAV optimization: potential for unintended consequences Enhanced and selective cardiac transduction: potential future strategiesRead more

day: Post-Conference Day

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.